European Medicines Agency (EMEA) Approves ALIMTAŽ (pemetrexed For Injection) For Use In Lung Cancer Treatment
Apr 17th 2008Drug InformationLung Cancer
OnApril 11, 2008, an announcement by Eli Lilly and Company (NYSE:LLY) indicated that European health authorities have approved theuse of ALIMTAŽ (pemetrexed for injection) for a histologically-baseduse in the first-line treatment of advanced non-small-cell lung cancer(NSCLC), the most common form of lung cancer.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
